Briefing: Where Will Nu Holdings Stock Be in 10 Years?
Strategic angle: Analyzing the future potential of Nu Holdings stock over the next decade.
Briefing: How gossiping mushroom networks share your public urination secrets
Strategic angle: Mushrooms communicate through underground networks, sharing secrets and information with their neighbors.
Briefing: Pinterest (PINS) Fell Following Softer Outlook
Strategic angle: Pinterest's stock experiences a decline due to a weaker than expected outlook.
Briefing: Stock Market Today: Dow Rises As Trump Gives Timetable For Truce; Nike Plunges On Earnings (Live Coverage)
Strategic angle: The Dow sees gains amid political developments while Nike's earnings report causes a significant drop.
Stocks Recover Sharply Amid Hope for Iran War’s End
Market rebounds as investors anticipate resolution in the ongoing conflict.
Briefing: S&P 500 Index Investors Burned In Nightmare-Scenario Market
Strategic angle: Investors in the S&P 500 Index face significant losses as market conditions worsen.
Briefing: Morning Brief: Stocks roar back, plus our giant, action-packed Q1 roundup
Strategic angle: Stocks rebound significantly as we review the key events of Q1.
Briefing: STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch
Strategic angle: Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter.
Briefing: So long Daniel Craig... The identity of the new James Bond has been revealed
Strategic angle: The casting news we’ve all been waiting for has finally dropped, and the reveal of Daniel Craig's successor as 007 may surprise some James Bond fans.
Briefing: Chinese government bonds emerge as lone war haven
Strategic angle: Yields on China’s debt are down marginally since the start of the conflict while those of other major economies have risen.
Briefing: A wild first quarter comes to an end: 6 charts that defined a chaotic stretch for stocks
Strategic angle: MarketWatch highlights key charts that illustrate the tumultuous first quarter for the stock market.
Here's What to Expect for Gold and Silver Mining Stocks as the Iran Conflict Continues
The Motley Fool analyzes the impact of ongoing geopolitical tensions on precious metal mining stocks.
Briefing: Women are making strides in education and employment. But an investing glass ceiling remains
Strategic angle: Women haven't broken through the glass ceiling when it comes to participation in the stock market. Societal norms and ongoing pay disparities are to blame.
Briefing: Snap climbs 13% as activist Irenic suggests changes to boost stock's value 7x
Strategic angle: Irenic Capital proposes significant changes to enhance Snap's market performance.
Briefing: Jim Cramer Says He Likes AeroVironment “But They Have This Contract That’s Being Contested”
Strategic angle: Jim Cramer shares his thoughts on AeroVironment amidst contract disputes.
Briefing: Should you 'buy the dip' amid the latest stock market volatility? What experts say
Strategic angle: Should you 'buy the dip' amid stock market volatility from the U.S.-Iran war? Here's what financial experts say about the strategy.
Briefing: Wall Street Split on Gaming and Leisure Properties, Inc. (GLPI)
Strategic angle: Analysts are divided on the future prospects of GLPI amidst changing market conditions.
Briefing: These Stocks Are Today’s Movers: Microsoft, McCormick, Unilever, Nike, and More
Strategic angle: A look at the stocks making headlines today in the financial markets.
Briefing: Analysts Bullish on Galiano Gold (GAU) Amid Strong Share Price Momentum
Strategic angle: Analysts express optimism for Galiano Gold as share prices show significant upward movement.
Briefing: Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity
Strategic angle: Researchers at the University of Bayreuth have deciphered key steps in the biosynthetic mechanism of fostriecin, a potential anti-cancer agent.